In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biotech Layoffs Hit Hardest In Discovery

Executive Summary

As the financing drought continues and their cash supplies dwindle, biotechs are resorting to big layoffs to drastically cut back on spending (See exhibit 1). But however rigorous a company's turnaround effort, the target of the layoffs always seems to be discovery research, with the remaining employees focusing on clinical programs.
Advertisement

Related Content

Having Cake & Eating It: Sunesis' Solution to the Development/Discovery Challenge
Leading a Biotech Through Crisis
Lion Seizes the Middle Ground
GPC: A Model for the Rest of Us
GPC: A Model for the Rest of Us
Vertex: Sticking To Its Story
Amylin/Lilly: Resurrections and Conversions
Amylin/Lilly: Resurrections and Conversions
Vertex: Sticking To Its Story

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001975

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel